Article
Circumventing the effect of product toxicity: development of a novel two-stage production process for the lantibiotic gallidermin.
Applied and environmental microbiology - 1 Mar 2007
Valsesia G, Medaglia G, Held M, Minas W, Panke S
Abstract excerpt
Lantibiotics such as gallidermin are lanthionine-containing polypeptide antibiotics produced by gram-positive bacteria that might become relevant for the treatment of various infectious diseases. So far, self-toxicity has prevented the isolation of efficient overproducing strains, thus hampering...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
